| Primary |
| Product Used For Unknown Indication |
46.4% |
| Drug Use For Unknown Indication |
19.5% |
| Pain |
6.2% |
| Back Pain |
4.0% |
| Sciatica |
3.5% |
| Headache |
3.0% |
| Hypertension |
3.0% |
| Generalised Oedema |
2.0% |
| Arthralgia |
1.2% |
| Atrial Fibrillation |
1.2% |
| General Anaesthesia |
1.2% |
| Pain In Extremity |
1.2% |
| Urinary Tract Infection |
1.2% |
| Diarrhoea |
1.0% |
| Lung Disorder |
1.0% |
| Lung Infection |
1.0% |
| Myocardial Ischaemia |
1.0% |
| Agitation |
0.7% |
| Bipolar I Disorder |
0.7% |
| Diabetes Mellitus |
0.7% |
|
| Cytolytic Hepatitis |
10.9% |
| Vertigo |
7.3% |
| Vomiting |
7.3% |
| Drug Dependence |
5.5% |
| Hepatitis Fulminant |
5.5% |
| Overdose |
5.5% |
| Pancreatitis Acute |
5.5% |
| Sepsis |
5.5% |
| Somnolence |
5.5% |
| Tachycardia |
5.5% |
| Abdominal Pain |
3.6% |
| Hypertension |
3.6% |
| Hyponatraemia |
3.6% |
| Malaise |
3.6% |
| Multi-organ Failure |
3.6% |
| Myoclonus |
3.6% |
| Oral Pain |
3.6% |
| Pallor |
3.6% |
| Palpitations |
3.6% |
| Pharyngeal Erythema |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
29.8% |
| Drug Use For Unknown Indication |
19.6% |
| Pain |
11.8% |
| Pyrexia |
5.1% |
| Sciatica |
5.1% |
| Drug Exposure During Pregnancy |
4.3% |
| Hypertension |
3.5% |
| Depression |
2.1% |
| Haemolytic Uraemic Syndrome |
2.0% |
| Headache |
1.9% |
| Nausea |
1.9% |
| Acute Myeloid Leukaemia |
1.8% |
| General Anaesthesia |
1.8% |
| Back Pain |
1.6% |
| Extragonadal Primary Germ Cell Tumour Mixed Stage I |
1.4% |
| Non-small Cell Lung Cancer |
1.4% |
| Pneumonia |
1.4% |
| Prophylaxis |
1.2% |
| Infection |
1.1% |
| Thrombosis Prophylaxis |
1.1% |
|
| Vomiting |
12.5% |
| Cytolytic Hepatitis |
9.4% |
| Liver Function Test Abnormal |
7.3% |
| Renal Failure Acute |
7.3% |
| Somnolence |
6.3% |
| Cholestasis |
5.2% |
| Haematoma |
4.2% |
| Hemiplegia |
4.2% |
| Intestinal Ischaemia |
4.2% |
| Malaise |
4.2% |
| Multi-organ Failure |
4.2% |
| Pancreatitis Acute |
4.2% |
| Presyncope |
4.2% |
| Skin Exfoliation |
4.2% |
| Subdural Haematoma |
4.2% |
| Gamma-glutamyltransferase Increased |
3.1% |
| Hyperhidrosis |
3.1% |
| Thrombocytopenia |
3.1% |
| Urticaria |
3.1% |
| Cardio-respiratory Arrest |
2.1% |
|
| Concomitant |
| Drug Use For Unknown Indication |
28.7% |
| Product Used For Unknown Indication |
15.9% |
| Pain |
7.4% |
| Hypertension |
6.7% |
| Rheumatoid Arthritis |
6.2% |
| Prophylaxis |
4.7% |
| Non-small Cell Lung Cancer |
3.8% |
| Premedication |
3.1% |
| Infection |
2.7% |
| Diarrhoea |
2.3% |
| Thrombosis Prophylaxis |
2.2% |
| Nausea |
2.2% |
| Therapeutic Embolisation |
2.2% |
| Constipation Prophylaxis |
1.9% |
| Multiple Myeloma |
1.9% |
| Hypokalaemia |
1.8% |
| Breast Cancer |
1.6% |
| Depression |
1.6% |
| Hepatic Neoplasm Malignant |
1.6% |
| Sarcoma Metastatic |
1.6% |
|
| Thrombocytopenia |
11.9% |
| Pleural Effusion |
9.3% |
| Vomiting |
9.3% |
| Weight Decreased |
6.6% |
| Renal Failure |
6.0% |
| Renal Failure Acute |
5.3% |
| Pyrexia |
4.6% |
| Respiratory Failure |
4.6% |
| General Physical Health Deterioration |
4.0% |
| Hepatocellular Injury |
4.0% |
| Neutropenia |
4.0% |
| Septic Shock |
4.0% |
| Vision Blurred |
4.0% |
| Granulocytopenia |
3.3% |
| Pancytopenia |
3.3% |
| Pulmonary Embolism |
3.3% |
| Sopor |
3.3% |
| Tachycardia |
3.3% |
| Transaminases Increased |
3.3% |
| Death |
2.6% |
|
| Interacting |
| Lung Disorder |
12.5% |
| Atrial Fibrillation |
10.4% |
| Drug Use For Unknown Indication |
10.4% |
| Pain |
10.4% |
| Urinary Tract Infection |
6.3% |
| Evidence Based Treatment |
4.2% |
| Gastroduodenal Ulcer |
4.2% |
| Hypertension |
4.2% |
| Hypokalaemia |
4.2% |
| Muscle Rigidity |
4.2% |
| Muscle Spasticity |
4.2% |
| Renal Colic |
4.2% |
| Schizophrenia |
4.2% |
| Urinary Retention |
4.2% |
| Acute Pulmonary Oedema |
2.1% |
| Analgesic Therapy |
2.1% |
| Arrhythmia Supraventricular |
2.1% |
| Arthralgia |
2.1% |
| Back Pain |
2.1% |
| Coagulopathy |
2.1% |
|
| Epilepsy |
15.4% |
| Weight Decreased |
15.4% |
| Hypocoagulable State |
7.7% |
| International Normalised Ratio Increased |
7.7% |
| Overdose |
7.7% |
| Renal Failure Acute |
7.7% |
| Respiratory Distress |
7.7% |
| Rhabdomyolysis |
7.7% |
| Subdural Haematoma |
7.7% |
| Urinary Tract Infection |
7.7% |
| Vomiting |
7.7% |
|
